The global market for Aminoglycoside Antibiotics was valued at US$ 1090 million in the year 2024 and is projected to reach a revised size of US$ 1364 million by 2031, growing at a CAGR of 3.3% during the forecast period.

Aminoglycoside Antibiotics Market

North American market for Aminoglycoside Antibiotics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Aminoglycoside Antibiotics is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Aminoglycoside Antibiotics include Britannica, Novartis Pharmaceuticals, Merck, Kremoint Pharma, Medson Pharmaceuticals, Allergan, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Aminoglycoside Antibiotics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aminoglycoside Antibiotics.

The Aminoglycoside Antibiotics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Aminoglycoside Antibiotics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Aminoglycoside Antibiotics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Aminoglycoside Antibiotics Market Report

Report Metric	Details
Report Name	Aminoglycoside Antibiotics Market
Accounted market size in year	US$ 1090 million
Forecasted market size in 2031	US$ 1364 million
CAGR	3.3%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Neomycin Tobramycin Gentamicin Amikacin Paromomycin Kanamycin
Segment by Application	Veterinary Respiratory UTI & Pelvic Disease Neonatal Sepsis
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Britannica, Novartis Pharmaceuticals, Merck, Kremoint Pharma, Medson Pharmaceuticals, Allergan
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Aminoglycoside Antibiotics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Aminoglycoside Antibiotics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Aminoglycoside Antibiotics Market growing?

Ans: The Aminoglycoside Antibiotics Market witnessing a CAGR of 3.3% during the forecast period 2025-2031.

What is the Aminoglycoside Antibiotics Market size in 2031?

Ans: The Aminoglycoside Antibiotics Market size in 2031 will be US$ 1364 million.

Who are the main players in the Aminoglycoside Antibiotics Market report?

Ans: The main players in the Aminoglycoside Antibiotics Market are Britannica, Novartis Pharmaceuticals, Merck, Kremoint Pharma, Medson Pharmaceuticals, Allergan

What are the Application segmentation covered in the Aminoglycoside Antibiotics Market report?

Ans: The Applications covered in the Aminoglycoside Antibiotics Market report are Veterinary, Respiratory, UTI & Pelvic Disease, Neonatal Sepsis

What are the Type segmentation covered in the Aminoglycoside Antibiotics Market report?

Ans: The Types covered in the Aminoglycoside Antibiotics Market report are Neomycin, Tobramycin, Gentamicin, Amikacin, Paromomycin, Kanamycin

1 Aminoglycoside Antibiotics Market Overview

1.1 Product Definition

1.2 Aminoglycoside Antibiotics by Type

1.2.1 Global Aminoglycoside Antibiotics Market Value Comparison by Type (2024 VS 2031)

1.2.2 Neomycin

1.2.3 Tobramycin

1.2.4 Gentamicin

1.2.5 Amikacin

1.2.6 Paromomycin

1.2.7 Kanamycin

1.3 Aminoglycoside Antibiotics by Application

1.3.1 Global Aminoglycoside Antibiotics Market Value by Application (2024 VS 2031)

1.3.2 Veterinary

1.3.3 Respiratory

1.3.4 UTI & Pelvic Disease

1.3.5 Neonatal Sepsis

1.4 Global Aminoglycoside Antibiotics Market Size Estimates and Forecasts

1.4.1 Global Aminoglycoside Antibiotics Revenue 2020-2031

1.4.2 Global Aminoglycoside Antibiotics Sales 2020-2031

1.4.3 Global Aminoglycoside Antibiotics Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Aminoglycoside Antibiotics Market Competition by Manufacturers

2.1 Global Aminoglycoside Antibiotics Sales Market Share by Manufacturers (2020-2025)

2.2 Global Aminoglycoside Antibiotics Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Aminoglycoside Antibiotics Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Aminoglycoside Antibiotics, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Aminoglycoside Antibiotics, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Aminoglycoside Antibiotics, Product Type & Application

2.7 Global Key Manufacturers of Aminoglycoside Antibiotics, Date of Enter into This Industry

2.8 Global Aminoglycoside Antibiotics Market Competitive Situation and Trends

2.8.1 Global Aminoglycoside Antibiotics Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Aminoglycoside Antibiotics Players Market Share by Revenue

2.8.3 Global Aminoglycoside Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Aminoglycoside Antibiotics Market Scenario by Region

3.1 Global Aminoglycoside Antibiotics Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Aminoglycoside Antibiotics Sales by Region: 2020-2031

3.2.1 Global Aminoglycoside Antibiotics Sales by Region: 2020-2025

3.2.2 Global Aminoglycoside Antibiotics Sales by Region: 2026-2031

3.3 Global Aminoglycoside Antibiotics Revenue by Region: 2020-2031

3.3.1 Global Aminoglycoside Antibiotics Revenue by Region: 2020-2025

3.3.2 Global Aminoglycoside Antibiotics Revenue by Region: 2026-2031

3.4 North America Aminoglycoside Antibiotics Market Facts & Figures by Country

3.4.1 North America Aminoglycoside Antibiotics Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Aminoglycoside Antibiotics Sales by Country (2020-2031)

3.4.3 North America Aminoglycoside Antibiotics Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Aminoglycoside Antibiotics Market Facts & Figures by Country

3.5.1 Europe Aminoglycoside Antibiotics Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Aminoglycoside Antibiotics Sales by Country (2020-2031)

3.5.3 Europe Aminoglycoside Antibiotics Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Aminoglycoside Antibiotics Market Facts & Figures by Region

3.6.1 Asia Pacific Aminoglycoside Antibiotics Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Aminoglycoside Antibiotics Sales by Region (2020-2031)

3.6.3 Asia Pacific Aminoglycoside Antibiotics Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Aminoglycoside Antibiotics Market Facts & Figures by Country

3.7.1 Latin America Aminoglycoside Antibiotics Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Aminoglycoside Antibiotics Sales by Country (2020-2031)

3.7.3 Latin America Aminoglycoside Antibiotics Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Aminoglycoside Antibiotics Market Facts & Figures by Country

3.8.1 Middle East and Africa Aminoglycoside Antibiotics Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Aminoglycoside Antibiotics Sales by Country (2020-2031)

3.8.3 Middle East and Africa Aminoglycoside Antibiotics Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Aminoglycoside Antibiotics Sales by Type (2020-2031)

4.1.1 Global Aminoglycoside Antibiotics Sales by Type (2020-2025)

4.1.2 Global Aminoglycoside Antibiotics Sales by Type (2026-2031)

4.1.3 Global Aminoglycoside Antibiotics Sales Market Share by Type (2020-2031)

4.2 Global Aminoglycoside Antibiotics Revenue by Type (2020-2031)

4.2.1 Global Aminoglycoside Antibiotics Revenue by Type (2020-2025)

4.2.2 Global Aminoglycoside Antibiotics Revenue by Type (2026-2031)

4.2.3 Global Aminoglycoside Antibiotics Revenue Market Share by Type (2020-2031)

4.3 Global Aminoglycoside Antibiotics Price by Type (2020-2031)

5 Segment by Application

5.1 Global Aminoglycoside Antibiotics Sales by Application (2020-2031)

5.1.1 Global Aminoglycoside Antibiotics Sales by Application (2020-2025)

5.1.2 Global Aminoglycoside Antibiotics Sales by Application (2026-2031)

5.1.3 Global Aminoglycoside Antibiotics Sales Market Share by Application (2020-2031)

5.2 Global Aminoglycoside Antibiotics Revenue by Application (2020-2031)

5.2.1 Global Aminoglycoside Antibiotics Revenue by Application (2020-2025)

5.2.2 Global Aminoglycoside Antibiotics Revenue by Application (2026-2031)

5.2.3 Global Aminoglycoside Antibiotics Revenue Market Share by Application (2020-2031)

5.3 Global Aminoglycoside Antibiotics Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Britannica

6.1.1 Britannica Company Information

6.1.2 Britannica Description and Business Overview

6.1.3 Britannica Aminoglycoside Antibiotics Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Britannica Aminoglycoside Antibiotics Product Portfolio

6.1.5 Britannica Recent Developments/Updates

6.2 Novartis Pharmaceuticals

6.2.1 Novartis Pharmaceuticals Company Information

6.2.2 Novartis Pharmaceuticals Description and Business Overview

6.2.3 Novartis Pharmaceuticals Aminoglycoside Antibiotics Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Novartis Pharmaceuticals Aminoglycoside Antibiotics Product Portfolio

6.2.5 Novartis Pharmaceuticals Recent Developments/Updates

6.3 Merck

6.3.1 Merck Company Information

6.3.2 Merck Description and Business Overview

6.3.3 Merck Aminoglycoside Antibiotics Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Merck Aminoglycoside Antibiotics Product Portfolio

6.3.5 Merck Recent Developments/Updates

6.4 Kremoint Pharma

6.4.1 Kremoint Pharma Company Information

6.4.2 Kremoint Pharma Description and Business Overview

6.4.3 Kremoint Pharma Aminoglycoside Antibiotics Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Kremoint Pharma Aminoglycoside Antibiotics Product Portfolio

6.4.5 Kremoint Pharma Recent Developments/Updates

6.5 Medson Pharmaceuticals

6.5.1 Medson Pharmaceuticals Company Information

6.5.2 Medson Pharmaceuticals Description and Business Overview

6.5.3 Medson Pharmaceuticals Aminoglycoside Antibiotics Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Medson Pharmaceuticals Aminoglycoside Antibiotics Product Portfolio

6.5.5 Medson Pharmaceuticals Recent Developments/Updates

6.6 Allergan

6.6.1 Allergan Company Information

6.6.2 Allergan Description and Business Overview

6.6.3 Allergan Aminoglycoside Antibiotics Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Allergan Aminoglycoside Antibiotics Product Portfolio

6.6.5 Allergan Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Aminoglycoside Antibiotics Industry Chain Analysis

7.2 Aminoglycoside Antibiotics Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Aminoglycoside Antibiotics Production Mode & Process Analysis

7.4 Aminoglycoside Antibiotics Sales and Marketing

7.4.1 Aminoglycoside Antibiotics Sales Channels

7.4.2 Aminoglycoside Antibiotics Distributors

7.5 Aminoglycoside Antibiotics Customer Analysis

8 Aminoglycoside Antibiotics Market Dynamics

8.1 Aminoglycoside Antibiotics Industry Trends

8.2 Aminoglycoside Antibiotics Market Drivers

8.3 Aminoglycoside Antibiotics Market Challenges

8.4 Aminoglycoside Antibiotics Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Britannica

Novartis Pharmaceuticals

Merck

Kremoint Pharma

Medson Pharmaceuticals

Allergan plc

List of Tables

Table 1. Global Aminoglycoside Antibiotics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Aminoglycoside Antibiotics Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Aminoglycoside Antibiotics Market Competitive Situation by Manufacturers in 2024

Table 4. Global Aminoglycoside Antibiotics Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Aminoglycoside Antibiotics Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Aminoglycoside Antibiotics Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Aminoglycoside Antibiotics Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Aminoglycoside Antibiotics Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Aminoglycoside Antibiotics, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Aminoglycoside Antibiotics, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Aminoglycoside Antibiotics, Product Type & Application

Table 12. Global Key Manufacturers of Aminoglycoside Antibiotics, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Aminoglycoside Antibiotics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Aminoglycoside Antibiotics as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Aminoglycoside Antibiotics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Aminoglycoside Antibiotics Sales by Region (2020-2025) & (K Units)

Table 18. Global Aminoglycoside Antibiotics Sales Market Share by Region (2020-2025)

Table 19. Global Aminoglycoside Antibiotics Sales by Region (2026-2031) & (K Units)

Table 20. Global Aminoglycoside Antibiotics Sales Market Share by Region (2026-2031)

Table 21. Global Aminoglycoside Antibiotics Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Aminoglycoside Antibiotics Revenue Market Share by Region (2020-2025)

Table 23. Global Aminoglycoside Antibiotics Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Aminoglycoside Antibiotics Revenue Market Share by Region (2026-2031)

Table 25. North America Aminoglycoside Antibiotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Aminoglycoside Antibiotics Sales by Country (2020-2025) & (K Units)

Table 27. North America Aminoglycoside Antibiotics Sales by Country (2026-2031) & (K Units)

Table 28. North America Aminoglycoside Antibiotics Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Aminoglycoside Antibiotics Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Aminoglycoside Antibiotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Aminoglycoside Antibiotics Sales by Country (2020-2025) & (K Units)

Table 32. Europe Aminoglycoside Antibiotics Sales by Country (2026-2031) & (K Units)

Table 33. Europe Aminoglycoside Antibiotics Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Aminoglycoside Antibiotics Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Aminoglycoside Antibiotics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Aminoglycoside Antibiotics Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Aminoglycoside Antibiotics Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Aminoglycoside Antibiotics Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Aminoglycoside Antibiotics Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Aminoglycoside Antibiotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Aminoglycoside Antibiotics Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Aminoglycoside Antibiotics Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Aminoglycoside Antibiotics Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Aminoglycoside Antibiotics Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Aminoglycoside Antibiotics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Aminoglycoside Antibiotics Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Aminoglycoside Antibiotics Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Aminoglycoside Antibiotics Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Aminoglycoside Antibiotics Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Aminoglycoside Antibiotics Sales (K Units) by Type (2020-2025)

Table 51. Global Aminoglycoside Antibiotics Sales (K Units) by Type (2026-2031)

Table 52. Global Aminoglycoside Antibiotics Sales Market Share by Type (2020-2025)

Table 53. Global Aminoglycoside Antibiotics Sales Market Share by Type (2026-2031)

Table 54. Global Aminoglycoside Antibiotics Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Aminoglycoside Antibiotics Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Aminoglycoside Antibiotics Revenue Market Share by Type (2020-2025)

Table 57. Global Aminoglycoside Antibiotics Revenue Market Share by Type (2026-2031)

Table 58. Global Aminoglycoside Antibiotics Price (USD/Unit) by Type (2020-2025)

Table 59. Global Aminoglycoside Antibiotics Price (USD/Unit) by Type (2026-2031)

Table 60. Global Aminoglycoside Antibiotics Sales (K Units) by Application (2020-2025)

Table 61. Global Aminoglycoside Antibiotics Sales (K Units) by Application (2026-2031)

Table 62. Global Aminoglycoside Antibiotics Sales Market Share by Application (2020-2025)

Table 63. Global Aminoglycoside Antibiotics Sales Market Share by Application (2026-2031)

Table 64. Global Aminoglycoside Antibiotics Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Aminoglycoside Antibiotics Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Aminoglycoside Antibiotics Revenue Market Share by Application (2020-2025)

Table 67. Global Aminoglycoside Antibiotics Revenue Market Share by Application (2026-2031)

Table 68. Global Aminoglycoside Antibiotics Price (USD/Unit) by Application (2020-2025)

Table 69. Global Aminoglycoside Antibiotics Price (USD/Unit) by Application (2026-2031)

Table 70. Britannica Company Information

Table 71. Britannica Description and Business Overview

Table 72. Britannica Aminoglycoside Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Britannica Aminoglycoside Antibiotics Product

Table 74. Britannica Recent Developments/Updates

Table 75. Novartis Pharmaceuticals Company Information

Table 76. Novartis Pharmaceuticals Description and Business Overview

Table 77. Novartis Pharmaceuticals Aminoglycoside Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Novartis Pharmaceuticals Aminoglycoside Antibiotics Product

Table 79. Novartis Pharmaceuticals Recent Developments/Updates

Table 80. Merck Company Information

Table 81. Merck Description and Business Overview

Table 82. Merck Aminoglycoside Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Merck Aminoglycoside Antibiotics Product

Table 84. Merck Recent Developments/Updates

Table 85. Kremoint Pharma Company Information

Table 86. Kremoint Pharma Description and Business Overview

Table 87. Kremoint Pharma Aminoglycoside Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Kremoint Pharma Aminoglycoside Antibiotics Product

Table 89. Kremoint Pharma Recent Developments/Updates

Table 90. Medson Pharmaceuticals Company Information

Table 91. Medson Pharmaceuticals Description and Business Overview

Table 92. Medson Pharmaceuticals Aminoglycoside Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Medson Pharmaceuticals Aminoglycoside Antibiotics Product

Table 94. Medson Pharmaceuticals Recent Developments/Updates

Table 95. Allergan Company Information

Table 96. Allergan Description and Business Overview

Table 97. Allergan Aminoglycoside Antibiotics Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Allergan Aminoglycoside Antibiotics Product

Table 99. Allergan Recent Developments/Updates

Table 100. Key Raw Materials Lists

Table 101. Raw Materials Key Suppliers Lists

Table 102. Aminoglycoside Antibiotics Distributors List

Table 103. Aminoglycoside Antibiotics Customers List

Table 104. Aminoglycoside Antibiotics Market Trends

Table 105. Aminoglycoside Antibiotics Market Drivers

Table 106. Aminoglycoside Antibiotics Market Challenges

Table 107. Aminoglycoside Antibiotics Market Restraints

Table 108. Research Programs/Design for This Report

Table 109. Key Data Information from Secondary Sources

Table 110. Key Data Information from Primary Sources

Table 111. Authors List of This Report

List of Figures

Figure 1. Product Picture of Aminoglycoside Antibiotics

Figure 2. Global Aminoglycoside Antibiotics Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Aminoglycoside Antibiotics Market Share by Type: 2024 & 2031

Figure 4. Neomycin Product Picture

Figure 5. Tobramycin Product Picture

Figure 6. Gentamicin Product Picture

Figure 7. Amikacin Product Picture

Figure 8. Paromomycin Product Picture

Figure 9. Kanamycin Product Picture

Figure 10. Global Aminoglycoside Antibiotics Market Value by Application (2020-2031) & (US$ Million)

Figure 11. Global Aminoglycoside Antibiotics Market Share by Application: 2024 & 2031

Figure 12. Veterinary

Figure 13. Respiratory

Figure 14. UTI & Pelvic Disease

Figure 15. Neonatal Sepsis

Figure 16. Global Aminoglycoside Antibiotics Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Aminoglycoside Antibiotics Market Size (2020-2031) & (US$ Million)

Figure 18. Global Aminoglycoside Antibiotics Sales (2020-2031) & (K Units)

Figure 19. Global Aminoglycoside Antibiotics Average Price (USD/Unit) & (2020-2031)

Figure 20. Aminoglycoside Antibiotics Report Years Considered

Figure 21. Aminoglycoside Antibiotics Sales Share by Manufacturers in 2024

Figure 22. Global Aminoglycoside Antibiotics Revenue Share by Manufacturers in 2024

Figure 23. Global 5 and 10 Largest Aminoglycoside Antibiotics Players: Market Share by Revenue in Aminoglycoside Antibiotics in 2024

Figure 24. Aminoglycoside Antibiotics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 25. Global Aminoglycoside Antibiotics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 26. North America Aminoglycoside Antibiotics Sales Market Share by Country (2020-2031)

Figure 27. North America Aminoglycoside Antibiotics Revenue Market Share by Country (2020-2031)

Figure 28. U.S. Aminoglycoside Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Canada Aminoglycoside Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Europe Aminoglycoside Antibiotics Sales Market Share by Country (2020-2031)

Figure 31. Europe Aminoglycoside Antibiotics Revenue Market Share by Country (2020-2031)

Figure 32. Germany Aminoglycoside Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. France Aminoglycoside Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. U.K. Aminoglycoside Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Italy Aminoglycoside Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Russia Aminoglycoside Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Asia Pacific Aminoglycoside Antibiotics Sales Market Share by Region (2020-2031)

Figure 38. Asia Pacific Aminoglycoside Antibiotics Revenue Market Share by Region (2020-2031)

Figure 39. China Aminoglycoside Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Japan Aminoglycoside Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. South Korea Aminoglycoside Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. India Aminoglycoside Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Australia Aminoglycoside Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Taiwan Aminoglycoside Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Indonesia Aminoglycoside Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Thailand Aminoglycoside Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Malaysia Aminoglycoside Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 48. Philippines Aminoglycoside Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Latin America Aminoglycoside Antibiotics Sales Market Share by Country (2020-2031)

Figure 50. Latin America Aminoglycoside Antibiotics Revenue Market Share by Country (2020-2031)

Figure 51. Mexico Aminoglycoside Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Brazil Aminoglycoside Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 53. Argentina Aminoglycoside Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 54. Middle East and Africa Aminoglycoside Antibiotics Sales Market Share by Country (2020-2031)

Figure 55. Middle East and Africa Aminoglycoside Antibiotics Revenue Market Share by Country (2020-2031)

Figure 56. Turkey Aminoglycoside Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. Saudi Arabia Aminoglycoside Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 58. U.A.E Aminoglycoside Antibiotics Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 59. Global Sales Market Share of Aminoglycoside Antibiotics by Type (2020-2031)

Figure 60. Global Revenue Market Share of Aminoglycoside Antibiotics by Type (2020-2031)

Figure 61. Global Aminoglycoside Antibiotics Price (USD/Unit) by Type (2020-2031)

Figure 62. Global Sales Market Share of Aminoglycoside Antibiotics by Application (2020-2031)

Figure 63. Global Revenue Market Share of Aminoglycoside Antibiotics by Application (2020-2031)

Figure 64. Global Aminoglycoside Antibiotics Price (USD/Unit) by Application (2020-2031)

Figure 65. Aminoglycoside Antibiotics Value Chain

Figure 66. Channels of Distribution (Direct Vs Distribution)

Figure 67. Bottom-up and Top-down Approaches for This Report

Figure 68. Data Triangulation

Figure 69. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Ibuprofen Sodium API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30X13296

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Enteric Gelatin Hollow Capsule Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-11U13426

Fri Mar 21 00:00:00 UTC 2025

$5800

Enterprise User

Add to Cart

Global Argatroban Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-16160

Fri Mar 21 00:00:00 UTC 2025

$8000

Enterprise User

Add to Cart

Global Contrast Agents Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

120 Pages

Type: Report

Code: QYRE-Auto-10G2665

Fri Mar 21 00:00:00 UTC 2025

$8000

Enterprise User

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions